Hemogenyx Pharma issues equity after exercise of warrants
Hemogenyx Pharmaceuticals PLC says warrants were exercised and new equity was issued, via a regulatory RNS dated 3 September 2026.
RNS Number: 1485T Hemogenyx Pharmaceuticals PLC 03 September 2026 3 September 2026THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED…